Concepedia

Theodore R. Holman

TR

Statistics

Publications

101

Citations

6.6K

H-Index

46

Active since

1987

Affiliations

University of California, Santa Cruz(Current)

National Institutes of Health

National Center for Advancing Translational Sciences

University of Michigan

University of California, San Francisco

Theodore R. Holman is an author at University of California, Santa Cruz specializing in life sciences, biochemistry, and pharmacology.

ORCID

Publications per year

1987–2024

101

Publications

101

PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals

Sally E. Wenzel, Yulia Y. Tyurina, Jinming Zhao et al. · Cell · 2017 · 920 citations · Full text

, , +9

N‐acetylcysteine targets 5 lipoxygenase‐derived, toxic lipids and can synergize with prostaglandin E <sub>2</sub> to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice

Saravanan S. Karuppagounder, Lauren Alin, Yingxin Chen et al. · Annals of Neurology · 2018 · 294 citations · Full text

, , +17

Pseudomonas aeruginosa utilizes host polyunsaturated phosphatidylethanolamines to trigger theft-ferroptosis in bronchial epithelium

Haider H. Dar, Yulia Y. Tyurina, Karolina Mikulska‐Ruminska et al. · Journal of Clinical Investigation · 2018 · 241 citations · Full text

, , +13

Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases

Joshua D. Deschamps, Victor Kenyon, Theodore R. Holman · Bioorganic & Medicinal Chemistry · 2006 · 164 citations · Full text

, , +5

Purification and characterization of VanR and the cytosolic domain of VanS: A two-component regulatory system required for vancomycin resistance in Enterococcus faecium BM4147

Gerard D. Wright, Theodore R. Holman, Christopher T. Walsh · Biochemistry · 1993 · 143 citations · Full text

, , +13

1–5 of 101